Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Filings indexed 399 across all filing types
Latest filing 2024-06-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for ST Pharm Co., Ltd. It details the meeting date, location, agenda items (such as board appointments and articles of association changes), and information regarding electronic voting. This document is a formal notice sent to shareholders to provide information and request their participation/votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2024-06-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to provide shareholders with information regarding upcoming shareholder meetings, including agenda items like board appointments and changes to the articles of incorporation. This document is specifically designed to solicit proxies for voting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-06-04 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Corporate Day). It provides details such as the date, location, purpose, and the agenda for the presentation. Since it is an announcement of an event and the availability of materials rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement of an event, it is classified as a Report Publication Announcement (RPA) or general regulatory filing. Given the specific nature of announcing an IR event, RPA is the most accurate fit.
2024-05-31 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, purpose, and the availability of IR materials on the company website. Since it is an announcement of an event and the availability of materials rather than the presentation itself, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2024-05-28 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for ST Pharm Co., Ltd. (에스티팜 주식회사) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial data, business operations, production capacity, and management information, which is characteristic of a formal quarterly financial report filed with the Financial Supervisory Service (금융위원회) and the Korea Exchange (한국거래소). Q1 2024
2024-05-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for ST Pharm, detailing the date, location, and agenda items such as the appointment of directors and audit committee members. In the context of corporate filings, documents that solicit votes and provide information for upcoming shareholder meetings are classified as Proxy Solicitation & Information Statements.
2024-05-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.